Latest News about DGX
Recent news which mentions DGX
A Look Into Healthcare Sector Value Stocks
February 28, 2022
From Benzinga
What 8 Analyst Ratings Have To Say About Quest Diagnostics
February 14, 2022
Tickers
DGX
From Benzinga
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services
February 03, 2022
Tickers
DGX
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
From Benzinga
CDC data confirms boosters offer high level of protection against severe COVID, bolster case for unvaccinated to get their shots
January 31, 2022
From MarketWatch
U.S. COVID daily death toll at highest level since last winter’s peak, and WHO says global case tally set record in latest week
January 26, 2022
Tickers
DGX
Tags
DGX
From MarketWatch
7 Undervalued Stocks That Won’t Stay That Way for Long
January 25, 2022
From InvestorPlace
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
January 12, 2022
Tickers
DGX
From Benzinga
3 COVID Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
From InvestorPlace
Overview Of Value Stocks In The Healthcare Sector
November 29, 2021
From Benzinga
7 Stocks to Buy as America Lifts Its Travel Ban
November 19, 2021
From InvestorPlace
Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers
November 12, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Quest Diagnostics
October 26, 2021
Tickers
DGX
From Benzinga
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
October 21, 2021
Tickers
DGX
From Motley Fool
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
October 21, 2021
Tickers
DGX
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
Next year will be ‘tricky’ for stockholders, so follow this road map, says RBC’s top strategist Lori Calvasina
October 21, 2021
From MarketWatch
Earnings Scheduled For October 21, 2021
October 21, 2021
From Benzinga
Why Shares of Ginkgo Bioworks Plunged Today
October 20, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.